SCHEMBL3174273

SCHEMBL3174273

COc1cccc(CC2(O)CCN(CC(=O)Nc3cc(NCCNC(C)=O)nc(-c4ccccc4)n3)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ CLK4 Q9HAZ1 1/20 0.46
▸ ADORA3 P0DMS8 3/20 0.45
▸ HTT P42858 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ GAA P10253 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ GRIN2B Q13224 2/20 0.41
▸ GFER P55789 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MTNR1A P48039 2/20 0.40
▸ MTNR1B P49286 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3155741 0.92 ADORA3 (0.48) TSHRCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL3162879 0.91 UTS2R (0.44) ADORA3GRIN2BADORA2AADORA2BADORA1
SCHEMBL3165572 0.89 ALDH1A1 (0.42) CYP2C19ADORA3KMT2AGRIN2BADORA2A
SCHEMBL3156070 0.88 TSHR (0.54) TSHRCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL3165120 0.86 UTS2R (0.39) ADORA3SMN1; SMN2USP2ADORA2AADORA2B
SCHEMBL3156668 0.84 MAPT (0.59) TSHRCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL3162796 0.82 ADORA3 (0.53) TSHRADORA3SMN1; SMN2USP2GAA
SCHEMBL3165134 0.82 ALDH1A1 (0.48) ADORA3HTTSMN1; SMN2LMNAKMT2A
SCHEMBL3163746 0.81 ALDH1A1 (0.50) ADORA3SMN1; SMN2MAPTGAAKMT2A
SCHEMBL3165286 0.80 USP2 (0.57) TSHRADORA3HTTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback